NSHS — Nanosphere Health Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.21m
- CA$0.29m
Annual cashflow statement for Nanosphere Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.356 | -0.282 | -0.228 | 0.263 | -0.085 |
| Depreciation | |||||
| Non-Cash Items | -0.037 | 0.053 | -0.024 | -0.523 | -0.094 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.328 | 0.161 | 0.199 | 0.223 | 0.156 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.065 | -0.068 | -0.054 | -0.036 | -0.023 |
| Financing Cash Flow Items | -0.008 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.182 | 0 | — | 0.029 | 0.027 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.118 | -0.076 | -0.046 | -0.007 | -0 |